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Abstract: One of the main fundamental mechanisms of antibiotic resistance in Gram-negative 
bacteria comprises an effective change in the membrane permeability to antibiotics. The 
Gram-negative bacterial complex cell envelope comprises an outer membrane that delimits 
the periplasm from the exterior environment. The outer membrane contains numerous protein 
channels, termed as porins or nanopores, which are mainly involved in the influx of hydrophilic 
compounds, including antibiotics. Bacterial adaptation to reduce influx through these outer 
membrane proteins (Omps) is one of the crucial mechanisms behind antibiotic resistance. Thus 
to interpret the molecular basis of the outer membrane permeability is the current challenge. 
This review attempts to develop a state of knowledge pertinent to Omps and their effective role 
in antibiotic influx. Further, it aims to study the bacterial response to antibiotic membrane per-
meability and hopefully provoke a discussion toward understanding and further exploration of 
prospects to improve our knowledge on physicochemical parameters that direct the translocation 
of antibiotics through the bacterial membrane protein channels.
Keywords: antibiotics, Gram-negative bacteria, cell envelope, protein channels, nanopores, 
influx, antibiotic resistance
Introduction
Antibiotic resistance can be defined as the capability of any microbial organism to coun-
terattack effects of antimicrobial drugs (antibiotics) (Figure 1A) used against them.1,2 
This phenomenon has become a global communal health threat due to an enormous 
increase in annual death rate.2 The emergence of highly resistant organisms has led to 
the requirement of new antibacterial drugs.1 Due to the slow progress of the current 
antibiotic research, there exists an enormous gap between bacterial evolution and the rate 
of development of novel antibiotic drugs.1,3,4 Only about two new classes of antibiotics 
have been brought to the market in the last three decades. On the technical front, there 
is an urgent need for a greater understanding of how antibiotics work, how bacteria 
progress with resistance against these antibiotics, and what molecular machinery could 
be exploited to get around bacterial defense mechanisms.1–4 The current innovative way 
of improving the potential of antibiotics is to effectively introduce them into bacteria 
and further prevent them from degradation by bacterial enzymes before they reach their 
targets. There is an extreme necessity for counteracting the problem of multi-antibiotic 
resistance.1,4 The important mechanism (Figure 1B) of resistance toward antibiotics 
known till date includes the enzymes-mediated deactivation of antibiotics for example, 
β-lactamase enzymes which hydrolyze and confer resistance against a diverse variety of 
antibiotics including penicillins, cephalosporins, carbapenems, and many more.4–7 The 
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outer membrane vesicles (Figure 1C), these native vesicles 
released by Gram-negative bacteria, are mainly composed 
of periplasmic and outer membrane components including 
lipopolysaccharides, proteins, lipids, and other molecules.8–11 
They help the producer cells while communicating with other 
cells concerning pathogenesis, secretion, nutrients acquisition, 
Figure 1 (A) Antibiotic resistance (an overview). (B) various mechanisms of antibiotic resistance employed by Gram-negative bacteria (an overview). (C) Structural 
representation of outer membrane vesicles.
Abbreviation: Omps, outer membrane proteins.
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and self-defense.5,8–10 These moieties protect bacteria from 
various environmental stress factors including antibiotics, 
for example, gentamicin, imipenem, ampicillin, melittin, 
colistin, and many more.8–14 Further, resistance mechanism 
is also mediated by reducing the entry of antibiotics into the 
target site of bacteria which is mainly effected by specific 
alteration of outer membrane permeability (Figure 2). Efflux 
pumps effectively contribute  towards resistance mechanism 
by antibiotic expulsion. In addition, antibiotic target proteins, 
for example, penicillin-binding proteins, are altered inside 
the bacterial cells, leading to antibiotic resistance.2,3,5,6,15–21
In this review, we present a systemic overview of the role 
of different membrane protein transporters responsible for 
antibiotic transport, present in the outer membrane of Gram-
negative bacteria.4–6,22 We highlight the different achievements 
of the scientific community in understanding the uptake of dif-
ferent solutes including antibiotics.7,17,22 This active knowledge 
of the role of outer membrane influx in antibiotic transport 
in Gram-negative bacteria can be useful for antibiotic drug 
development in the future, where the computed data can be 
employed toward understanding the detailed mechanism of 
bacterial membrane transport, and to further design novel 
antibiotics with an effective permeability profile.
Gram-negative bacteria
Gram-negative bacteria have a multifaceted cell envelope 
comprising an outer membrane that restricts the access to the 
periplasm by acting as a molecular filter, thus forming an effi-
cient selective permeation barrier.4–6,23,24 This outer membrane, 
like other biological membranes, is fundamentally built up of 
a bilayer of lipids.6,18,25,26 As such, this lipid bilayer membrane 
is mostly impermeable to hydrophilic molecules including 
nutrients.22,25,27 The effective intake of hydrophilic molecules 
is mainly controlled by specific water-filled open channels 
termed as outer membrane proteins (Omps) or porins.22,27–29 
These Omps are intensively characterized in Gram-negative 
bacteria and are further distinguished as nonspecific and 
specific Omps in accordance with their functional structure 
(monomeric or trimeric),6,7,22,24–26,28 substrate specificity, 
regulation, and expression.15,18,29,30 These membrane proteins 
do not show any hydrophobic stretches in their amino acid 
sequences and majorly form hollow β-barrel structures 
with a hydrophobic outer surface.28,31 The barrel structure 
encompasses the transmembranous pore-type structure with a 
crucial function of facilitating the passive flux of hydrophilic 
substances22,28 and further acting as a functional diffusional 
barrier for nonpolar solutes.6,28 These proteins might show 
specific selectivity in general for either cations or anions.5,22,28
Bacterial adaptation to reduce influx through these 
Omps is an increasing problem that contributes, together 
with efflux systems, to antibiotic resistance.3–5,20,23,32–34 An 
existing challenge for drug design is to interpret membrane 
permeability at molecular level to get a better insight into the 
role of membrane transport (Figure 2) in bacterial resistance 
mechanism.4–7,20,35 Like other hydrophilic molecules, polar 
antibiotics including β-lactam antibiotics and fluoroquino-
Figure 2 Antibiotic resistance mechanism associated with Omps modification. Antibiotic β-lactam molecules are represented by green stars, and Omps as trimers by gray 
cylinder. The width of the straight arrows imitating the level of β-lactam penetration via Omps. The curved arrows exemplify the uptake failure/reduce uptake occurring with 
the following: B: decrease in the level of wild-type Omps expression; C: expression of restricted-channel Omps; D: mutation or modification of the functional properties of 
a porin channel; and E: synthesis of modified Omps with significant constriction.
Abbreviation: Omps, outer membrane proteins.
A. Synthesis of wild-type Omps
B. Suppressed synthesis of wild-type Omps
C. Synthesis of restricted Omps
D. Mutation of Omps
E. Synthesis of wild-type Omps with constricted channel
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lones majorly sneak into Gram-negative bacteria using these 
Omps.5,31,33 Any slight modification by the bacteria in the 
responsible Omps can significantly affect the antibiotic drug 
therapy.33 Many clinically pertinent bacterial species includ-
ing Enterobacter aerogenes, Escherichia coli, Enterobacter 
cloacae, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
and Acinetobacter baumannii have been sequenced for deter-
mining the effective key Omps (Table 1) present in the outer 
membrane.3–6,23,28,31–33,36,37 Further, bacterial bugs including 
Pseudomonas aeruginosa, and Acinetobacter baumannii 
possess an innate low vulnerability toward β-lactams, through 
reduced outer membrane permeability.5,6,20,22,38 For instance, 
reduced membrane permeability in Pseudomonas aeruginosa 
as compared to Enterobacteriaceae mainly occurs due to less 
number of Omps present in the outer membrane and their 
distinct physicochemical properties.22,38–41 In other Gram-
negative bugs, for example, Escherichia coli, Enterobacter 
and Klebsiella pneumoniae, susceptibility toward β-lactam 
molecules is closely related to the presence of nonspecific 
diffusion Omps, for example, OmpF and OmpC.5,6,22
Previous works showing the effective role of different 
Omps (Table 1) in molecular influx of different antibiotics are 
shown in Table 2. We discuss the achievements of the scien-
tific community in this area by studying the role of different 
Omps in outer membrane permeability, using separate set of 
theoretical and experimental techniques including molecular 
simulation (MS), electrophysiology, minimum inhibitory 
concentration assay, liposome swelling assay, X-ray crystal-
lography, and fluorescence resonance energy transfer.
Discussion
Computing influx
Typical antibiotic activity toward bacterial cell occurs in 
micromolar concentration range, thereby representing val-
ues that are approximately limited to a thousand molecules 
inflowing the cell in few minutes to hours.7,22 Such numbers 
are considerably beneath the detection limit of most of the 
techniques and thus require significant amplification of the 
signal.4,7,22,110 Measuring the flux of small molecules across 
the outer cell membrane can be possibly achieved by differ-
ent approaches including whole-cell assays, which require 
computation of flux using genetically engineered bacterial 
cell.7,111,112 These methods involve soaking bacteria in anti-
biotics for a fixed time followed by a separation process to 
remove the external media from the internalized antibiotics.7 
However, the quality of the separation method is crucial for 
improving permeability.7,111,112 There are several published 
studies employing whole-cell assays to quantify the uptake, 
and their quality has been intensively compared.7,110–116 Once 
the separation technique allows collecting sufficient amounts 
of internalized antibiotics, several biophysical methods can 
be used to quantify the intracellular antibiotics.7,113–118 One of 
the promising tools for studying intracellular accumulation is 
mass spectrometry. The technique was successfully applied 
in measuring the uptake of antibiotics;117,118 for example, a 
work demonstrated cellular uptake of linezolid by E. coli 
using liquid chromatography–mass spectrometry.118
The discussed methods allow quantifying the total turn-
over of a cell uptake which represents the relevant actual 
effective concentration seen by the bacteria. On the contrary, 
the comprehensive flux depends on a multitude of parameters 
and renders the molecular understanding difficult.7,22 To 
understand the molecular origin of the antibiotic uptake, we 
need information on the role of each individual involved com-
ponent. For example, the so-called liposome swelling assay 
provides information on a model system.35,52,55,60,80,97,105 The 
method involves reconstitution of batches of purified Omps 
into (multilamellar) liposomes.7,22 Under isosmotic addi-
tion, the diffusion of substrate inside the liposome results in 
alteration of the light-scattering  pattern. The effective change 
Table 1 Crucial Omps studied in different Gram-negative bacterial species 
Species Investigative porins or Omps
Escherichia coli (E. Coli) OmpC,19,42–49 OmpF,7,19,21,36,42–46,49–74 Phoe75–76
Enterobacter aerogenes (E. aerogenes) Omp36,16,49,77–79 Omp3549,77,78,80
Enterobacter cloacae (E. cloacae) Ompe36,81 Ompe35
Klebsiella pneumoniae (K. pneumoniae) OmpK36,42,49,82 OmpK3542,49,82
Pseudomonas aeruginosa (P. aeruginosa) OccD1 (OprD), OccD2 (OpdC), OccD3 (OpdP), OccD4 (OpdT), OccD5 (OpdI), OccD6 (OprQ), OccD7 
(OpdB), OccD8 (OpdJ)83–91
OccK1 (OpdK), OccK2 (OpdF), OccK3 (OpdO), OccK4 (OpdL), OccK5 (OpdH), OccK6 (OpdQ), OccK7 
(OpdD), OccK8 (Opre)61,88,89,92–98
OprO,99 OprP90,99–102
Acinetobacter baumannii (A. baumannii) OccAB1–OccAB5,35 rOprD,103 CarO104,105
Notes: Studies by Nikaido,5,6 Pages et al,22,42 and Schulz28 provide further insight.
Abbreviation: Omps, outer membrane proteins.
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Table 2 Conclusive investigations with different Omps studied in different Gram-negative bacterial species
Conclusive investigation Omps Species
Measured the flux of charged β-lactamase inhibitors sulbactam, tazobactam, and avibactam using eTP zero-
current assay and MS36
OmpF E. coli
Measured the transport of charged β-lactamase inhibitors sulbactam, tazobactam, and avibactam using eTP 
zero-current assay59
OmpC E. coli
Measured the permeability of carbapenems via different mutant proteins from different clinical isolates using 
eTP and LSA52
OmpC E. coli
Quantified norfloxacin uptake using semiquantitative optofluidic assay56 OmpF E. coli
Quantified and explained the mechanism of small antibiotic molecule enrofloxacin uptake using ETP and MS7 OmpF E. coli
Quantified and demonstrated the translocation of imipenem, ceftazidime, and cefepime using ETP74 OmpF E. coli
Demonstrated the interaction and binding of antibiotic meropenem with channel using eTP53 OmpF E. coli
Demonstrated the translocation of polypeptides using eTP64 OmpF E. coli
Demonstrated the permeation of enrofloxacin across the OmpF channel and modulation of the affinity site 
in the presence of magnesium using eTP and MS54,66,72
OmpF E. coli
Demonstrated the transport of ampicillin and benzylpenicillin using eTP, MS, MIC, and LSA60 OmpF E. coli
Demonstrated the role of charged residues in channel constriction, channel conductance, ion selectivity, and 
voltage gating using eTP and MS71
OmpF E. coli
Demonstrated important electrostatic interactions between ions and charge distribution within the channel 
that govern ion permeation and selectivity using MS62
OmpF E. coli
Demonstrated the ionization states of titratable amino acid residues and calculated self-consistently the 
electric potential distribution within channel using MS50
OmpF E. coli
Demonstrated the movement of single ampicillin molecule via channel using eTP and MS67 OmpF E. coli
Demonstrated the molecular origin of cation selectivity within Omps by defining the effect of alkali metal 
ions atomic radii on the binding-site affinity using ETP and MS58
OmpF E. coli
Demonstrated the specific interaction of grepafloxacin, ciprofloxacin, moxifloxacin, and nalidixic acid with 
pore using Uv–visible spectroscopic measurements68
OmpF E. coli
Demonstrated the permeation of moxifloxacin across membrane channel and protein–antibiotic interaction 
using eTP, MS and FReT65
OmpF E. coli
Investigated the effects of four polyamines (putrescine, cadaverine, spermidine, and spermine) on the activity 
of bacterial porins using eTP patch clamp106
OmpF E. coli
Demonstrated the channel functional characteristics of four single amino acid substitutions and effect of 
deletion mutant in constriction loop L3 using eTP107 and crystallographic analysis108
OmpF E. coli
Demonstrated the role of the constriction loop in voltage gating using eTP and crystallographic analysis109 OmpF E. coli
Employed fluorescence quenching as a tool to investigate the antibiotic interactions with bacterial protein, 
using nalidixic acid and moxifloxacin, within the pore69
OmpF E. coli
Demonstrated ampicillin translocation through the bacterial pore, and described the effect of mutations 
within pore affecting molecule passage using eTP and MS61
OmpF E. coli
Provided a descriptive explanation about pathways of ions along channel surface using MS70 OmpF E. coli
Probed the interaction of peptides, magainin 2, and HPA3P with the pore, and displayed the effect of electric 
field on pore and peptide geometry using ETP51
OmpF E. coli
Demonstrated the translocation of ampicillin using multiscale approach combined with MS63 OmpF E. coli
Demonstrated the effective binding of carbenicillin, ertapenem, and ampicillin within the pore using X-ray 
crystallography and MS21
OmpF E. coli
Demonstrated the interaction involved in translocation of ampicillin, amoxicillin, carbenicillin, azlocillin, and 
piperacillin using eTP and MS57
OmpF E. coli
Demonstrated the effect of specific acid residue D113A substitution on susceptibility to cefepime, 
cefpirome, cefotaxime, ceftazidime, cefoxitin, and ampicillin using MIC and MS73
OmpF E. coli
Demonstrated the effective role of anti-loop 3 (Lys-16) residue in cefepime diffusion using LSA, eTP, and 
MS55
OmpF E. coli
Demonstrated the effect of ion concentration and charged residues at constriction zone on gating behavior 
of channel using eTP47
OmpC E. coli
established the effect of three mutations within porins isolated from multidrug-resistant E. coli on transport 
of cefotaxime using MIC, eTP, and MS48
OmpC E. coli
Studied the interaction strengths of ceftriaxone, cefpirome, and ceftazidime using effective fluorescence 
quenching and ETP44
OmpC, OmpF E. coli
Demonstrated the influx of ceftriaxone, cefepime, ceftazidime, norfloxacin, ciprofloxacin, and enrofloxacin  
using a chip-based automated patch clamp technique based on ETP45
OmpC, OmpF E. coli
(Continued)
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Conclusive investigation Omps Species
Demonstrated the effect of culture medium on porin expression and piperacillin–tazobactam susceptibility 
using MIC46
OmpC,  OmpF E. coli
Using water as a probe, demonstrated macroscopic electric field inside water-filled channels using MS43 OmpF, OmpC E. coli
Demonstrated the permeation of imipenem and meropenem to be dependent on electric dipole alignment of 
the molecule with an internal electric field of Omps, and identified the “preorientation” region within Omps 
affecting antibiotic pathway using MS19
OmpF, OmpC E. coli
Demonstrated how the excess fixed positive charges within the Omps result in the characteristic anion 
selectivity using eTP75
Phoe E. coli
Demonstrated the effect of amino group (lysines) and carboxyl groups on pore ion selectivity using eTP76 Phoe E. coli
Demonstrated drug resistance by mutational loss of Omps, and measured the quantitative influx rates of 
ampicillin, benzylpenicillin, oxacillin, cloxacillin, cephalothin, cephaloridine, cefoxitin, cefamandole, cefotaxime, 
ceftazidime, ceftriaxone, cefepime, imipenem, ertapenem, novobiocin, and erythromycin using MIC49
OmpK35, 
OmpK36
K. pneumoniae
OmpF, OmpC E. coli
examined the role of Omps in diffusion of ceftazidime–avibactam across the outer membrane using MIC42 Omp35, 
Omp36
E. aerogenes
OmpK35, 
OmpK36
K. pneumoniae
OmpF, OmpC E. coli
Studied imipenem resistance as a function of outer membrane permeability in different resistant clinical 
isolated strains using MIC77,78
Omp36, 
Omp35
E. aerogenes
Demonstrated the role of porin in selective susceptibility toward ceftriaxone using LSA and eTP80 Omp35 E. aerogenes
Demonstrated the effect of porin on the influx of ertapenem and cefepime using ETP and MIC16 Omp36 E. aerogenes
Demonstrated resistance due to porin mutation, affecting permeability of imipenem, cefepime, and 
cefpirome, in clinical strains using MIC79
Omp36 E. aerogenes
Demonstrated the effect of Omps on bacterial resistance to ceftazidime–avibactam, tigecycline, and colistin 
in clinical strains using MIC82
OmpK36, 
OmpK35
K. pneumoniae
Reported single-channel activity including broad-range conductance, gating dynamics, and cation selectivity 
for Omps subfamily using eTP84
OccD1–OccD6 P. aeruginosa
explained the outer membrane uptake and characterized the carboxylate group interaction with central 
residues of the basic ladder (arginine and lysine) residues using eTP83
OccD1–
OccD6, 
OccK1–OccK7
P. aeruginosa
Demonstrated channel activity conductance, gating transitions, one-open substate (K3), two-open substate 
(K4–K6), and three-open substate (K1, K2, K7) kinetics, anion selectivity, and positive residues within 
central constriction of the Omps using eTP89
OccK1–OccK7 
(K1–K7)
P. aeruginosa
elucidated conductance, gating properties, and the effect of internal constriction loop deletion on gating 
transitions using MS96
OccK1 P. aeruginosa
Demonstrated gating dynamics comprising enthalpy-driven and entropy-driven current transitions and the 
effect of loop deletion on activation enthalpies and entropies over channel transitions using eTP93
OccK1 P. aeruginosa
Demonstrated the effect of ion concentrations on gating transitions of the channel using eTP94 OccK1 P. aeruginosa
Provided a structural insight into substrate specificity and channel structure with monomeric 18-stranded 
β-barrel ensuing narrow constriction within pore using crystallography, X-ray, and eTP85
OccD1 P. aeruginosa
Studied the role of specific surface loop regions within pore determining imipenem passage using ETP86 OccD1 P. aeruginosa
Demonstrated the translocation of natural amino acid substrates to understand structure and dynamics of 
pore using MS87
OccD1 P. aeruginosa
Demonstrated the uptake of imipenem and meropenem using eTP91 OccD3 P. aeruginosa
Demonstrated the role of Omps in the uptake of tricarboxylate, isocitrate, and citrate using eTP98 OccK5 P. aeruginosa
Demonstrated diverse gating properties of the channel using eTP and MS95 OccK5 P. aeruginosa
Demonstrated the involvement of the Omps in temocillin transport into a bacterial cell using MIC92 OccK1, OccK2 P. aeruginosa
Demonstrated the ion selectivity of phosphate-specific pore, and established the energetics for transport of 
phosphate, sulfate, chloride, and potassium ion using MS90,102
OprP P. aeruginosa
Demonstrated the role of central-binding negatively charged residue (D94) in phosphate binding and 
selectivity using eTP and MS101
OprP P. aeruginosa
Investigated the role of central arginine (R133) in defining selectivity and ion transport properties of the 
pore using eTP and MS100
OprP P. aeruginosa
Demonstrated the effects of double mutations resulting in interchange of phosphate and diphosphate 
specificities of Omps using ETP and MS99
OprP, OprO P. aeruginosa
(Continued)
Table 2 (Continued)
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in light-scattering signal is then correlated with the relative 
permeability of the molecules. The main disadvantage of 
this method is that it requires a large quantity of material 
and is only effective for uncharged molecules, whereas for 
charged molecules, the effect of counterion flow affects the 
quality of the measurement. Moreover, the assay can only 
determine average turnover numbers and often does not 
provide conclusive values.7
Moreover, using conventional electrophysiology, compu-
tation of rate of flux of discrete small molecules across Omps 
present in bacterial outer cell membrane involves measure-
ment of flux values at single molecular level.7,36,45,52,56,66,67 
Here, electrophysiological measurement using single Omps 
provides the best high-resolution (Figure 3) signal-to-noise 
ratio,7,18,40,73,74,83 thereby suggesting the higher efficacy of this 
method in sensing and understanding uptake at molecular 
level.7,15,22 The method includes reconstitution of a single or 
multiple Omps into an artificial planar lipid bilayer and fur-
ther uses transmembrane potential-driven ion current across 
the channel as a detection probe.7,67 Using ion current as a 
probe specifically demonstrates very well-characterized elec-
trophysiological properties of the Omps,15,34,45,65,66,84,106,119–121 
including size,122,123 single-channel conductance, channel 
ion selectivity,58,75,76,90,99–101 channel gating dynamics, and 
more.47,95,109 Likewise, the size of Omps is a key factor defin-
ing transport through the channel.107,108 This factor plays a key 
role in antibiotic susceptibility.72–74 Determination of the size 
of Omps using electrophysiology provides a crucial insight 
into the maximum size of molecule they can transport.122,123 
This, further, helps in evaluating the inner structure including 
constriction site.122–125 Further, single-channel conductance of 
Omps, ion selectivity,58,75,76,84,89 and gating dynamics35,47,94,95,109 
give an insight into the channel–substrate binding and chan-
nel–substrate interactions.35,71,83,85,97,99,101 An insight into the 
channel conductance can be obtained, specifically using 
staircase electrophysiology (Figure 3A and B), where real-
time insertions of single channels at constant voltage can be 
attained.59,123 The conductance of any channel can be termed 
as its unique characteristic. This allows a better understand-
ing of the open/close states of the channel and its gating 
dynamics which can then be employed in studying channel 
structure–activity relationship.35,71,107,108
Using these functions, a proper insight into the channel 
interaction with different substrates can be obtained includ-
ing substrate-induced partial or full blockage ( Figure 3C) 
of channel52,53,67 and substrate-induced gating.67 The func-
tion of these pores has been well documented on the basis 
of pore characteristics, chemical modification, and genetic 
mutations.15 These parameters were further used to elabo-
rate transport of the following antibiotics: meropenem,52 
imipenem,52 cefotaxime,48 cefpirome,44 ceftriaxone,44,45 
cefepime,45 ceftazidime,44,45 ciprofloxacin,45 norfloxacin,45 and 
enrofloxacin45 through OmpC; imipenem,74 meropenem,53 
ceftazidime,44,45,74 cefepime,45,55,74 ceftriaxone,44,45 cefpi-
rome,44 ampicillin,57,60,61,67 benzylpenicillin,60 amoxicillin,57 
carbenicillin,57 azlocillin,57 piperacillin,57 ciprofloxacin,45 
norfloxacin,45,56,126 enrofloxacin,7,45,54,66,72 moxifloxacin,65 
different poly arginines,64 polyamines,106 and antimicrobial 
peptides51 through OmpF; ceftriaxone80 through Omp35; 
cefepime16 through Omp36; imipenem91 and meropenem91 
through OccD3; imipenem86 through OccD1; and merope-
nem,104 glutamic acid,104 arginine,104 and imipenem104 through 
CarO Omp (Table 2).
In contrast, single-channel recording provides the best 
signal-to-noise ratio and intrinsic data on Omp–substrate 
interaction.40,45,65–67 But the interpretation of molecule 
Conclusive investigation Omps Species
Demonstrated the structural features responsible for transport of amino acid residues via substrate-specific 
channel using LSA, eTP, and MS97
OccK8 P. aeruginosa
Demonstrated Omps uptake of glycine and ornithine and no uptake of glutamic acid, glucose, and imipenem 
using LSA and MS105
CarO isoforms 
CarO1, CarO2, 
CarO3
A. baumannii
Demonstrated channel conductance, cationic selectivity, and specificity toward meropenem, glutamic acid, 
arginine, and imipenem using eTP104
CarO A. baumannii
Demonstrated the function of the Omps in imipenem, meropenem, colistin, ceftazidime, and ciprofloxacin 
uptake using MIC103
rOprD 
homologue
A. baumannii
Demonstrated Omps substrate specificities toward glycine, ornithine, arginine, putrescine, glutamic acid, 
glucose, maltose, benzoic acid, phenylalanine, tryptophan, imipenem, meropenem, ceftazidime, ampicillin, and 
fosfomycin using LSA and eTP35
OccAB1–
OccAB4
A. baumannii
Abbreviations: Omps, outer membrane proteins; eTP, electrophysiology; MS, molecular simulation; LSA, liposome swelling assay; MIC, minimum inhibitory 
concentration; FRET, fluorescence resonance energy transfer.
Table 2 (Continued)
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 translocation cannot be made directly as the chances of 
molecule exit on the entry side are almost identical when 
compared to the transport of the molecule across the pore.7 
Whereas in the case of charged molecules, direct conclusion 
of translocation can be made as the increasing voltage will 
reduce the residence time of the molecules inside the Omp, 
which might provide some evidence of transport across the 
Omp. In addition, using channel selectivity, that is, channel 
inherent selection of either anion or cation, a quantitative flux 
assessment of the charged molecules can be made using elec-
trophysiological reversal potential measurements.36,59 Using 
this approach, flux of β-lactamase inhibitors across OmpF 
and OmpC was estimated, showing the role of Omps in their 
transport across bacterial biobarrier.36,59 However, most of the 
molecules did not carry a net charge or show low intrinsic 
solubility which makes them trivial to measure and thus 
excludes them from screening via this method. Furthermore, 
the finite time resolution of electrophysiology also makes 
the method limited in screening of antibiotics uptake.7,45,66,67
Molecular simulation
In the current scenario, MS is well suited to obtain a particu-
lar information at an atomic scale.121 Thus far, knowledge of 
the antibiotic translocation problem has pointed essentially 
toward three mechanisms including diffusion with molecule 
binding, a mechanism based on pore dehydration induced by 
the permeating molecule, and slow diffusion with molecule 
binding.50,61,62,70,71,97,99,121 Further, to discriminate among 
these mechanisms, and to attain a better description of the 
Omps behavior and their role in substrate transport, under-
standing the communication between pore and substrate is 
essential.119–121,127,128 Thanks to the high-resolution, molecular 
Figure 3 (A) Current recorded using staircase electrophysiology. A graphical representation depicting insertion of Omp over real time under applied potential. Recording 
time: 18 seconds. (B) Current histogram for the trace with each peak resembling a single Omp, showing, in total, approximately 45 Omps. (C) OmpF single channel–substrate 
interaction comparison: without substrate (blank), substrate 1 depicting no blockages, and substrate 2 inducing well-resolved channel blockage; a clear difference between 
the two substrates can be seen.
Abbreviation: Omp, outer membrane protein.
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modeling simulations, detailed characterization is possible 
in terms of energetics (Figure 4 from Ghai et al)36 and bond 
formation including hydrogen bonds, hydrophobic contacts, 
and more.50,62,71,121
The complete control over the characteristics of the sys-
tem allows MS to explain the impact of pinpoint mutations 
and the effects that arise due to different domains of the same 
proteins.95,100,101 Further, MS significantly allows understand-
ing and interpreting available experimental data.50,61,62,70,121 
When combined with experimental approach, MS proves 
to be a complementary method. For instance, together with 
electrophysiology,36,48,54,55,57,58,60,61,65–67,71–73,95,97,99–101 MS was 
used for understanding the transport of β-lactamase inhibitors 
(Figure 4), interaction of substrates with Omps (enrofloxacin, 
moxifloxacin, ampicillin, benzylpenicillin, carbenicillin, 
amoxicillin, azlocillin, piperacillin, ertapenem, imipenem, 
meropenem, cefepime, cefpirome, cefotaxime, ceftazi-
dime, cefoxitin, and cefepime with OmpF;7,19,21,36,50,54,55,57,58, 
60–63,65–67,70–73 cefotaxime, imipenem, and meropenem with 
OmpC;19,48 natural amino acids with OccD1),87 ion transport 
including transport of phosphate potassium and chloride 
ion via OprP90,100–102 and OprO,99 and interaction of glycine 
ornithine, glucose, and imipenem with CarO isoforms.105 Fur-
ther, for liposome swelling55,60,97,105 and minimum inhibitory 
concentration assay48,60,73 (not described), MS was helpful 
for understanding and interpreting the experimental results.
Figure 4 (A) Intrinsic depiction of the two-dimensional free energy of translocation of β-lactamase inhibitor (avibactam), reassembled from metadynamic simulations. (B) 
Lateral view and (C) topmost view of the avibactam inside OmpF pore in the two lowest minima near the constriction region and at the subsequent transition state. Reprinted 
with permission from Ghai I, Pira A, Scorciapino MA, et al. General method to determine the flux of charged molecules through nanopores applied to beta-lactamase 
inhibitors and OmpF. J Phys Chem Lett. 2017;8(6):1295–1301.36 Copyright (2017) American Chemical Society.
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Rationalizing the process of permeation of antibiotics 
into Gram-negative bacteria via MS requires an accurate and 
exhaustive description of some key molecular properties of 
the antibiotic molecule.121 MS is the best alternative tool to 
obtain homogenously derived physical–chemical descriptors 
for molecules with or without experimental approach.121,127,128 
MS based on all-atom empirical force fields with the resolu-
tion in microsecond time range and beyond could potentially 
provide a good level of description of the structural and 
dynamical properties of biological systems.119,121,127,128
Toward translational research
Translational research on understanding antimicrobial resis-
tance has led to implausible development in recent years4,129 
together with the expansion of novel techniques including 
proteomic analyses, high-sensitivity mass spectrometry, com-
putational bioinformatics, and many more approaches.4 For the 
most part, the discovery of novel technologies, the development 
of new infrastructures, along with the training of budding sci-
entists have reinforced this evolution.1,4,129,130 But the transition 
is still not complete, and roadblocks still exist on the path to 
scientific progress, for example, combining different data into 
a shared database that can be intrinsically used to understand 
how Omps located in the outer membrane of Gram-negative 
bacteria are able to filter molecular influx.24 The imperative need 
for new, effective Gram-negative antibacterial drugs comes at 
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a time when techniques needed for innovative assays can pro-
vide significant crucial data over understanding the effective 
bottleneck.4 Ideally, the overall penetration–efflux puzzle4 will 
form part of a larger understanding of the Gram-negative cell 
envelope as well as direction on how to create small molecules 
that can easily penetrate across the outer membranes.4 This 
information should move the antibacterial research community 
toward more rational approaches, which may enable the delivery 
of new agents to treat life-threatening infections.1,4,129,130
Conclusive remarks
This review summarizes the progressive scientific evidence 
explaining the role of Omps in membrane permeability of 
Gram-negative bacteria. The control of bacterial membrane 
permeability is a complex process that is strongly struc-
tured by an intricate network of arrangements that senses 
and retorts to pH, osmotic shock, temperature, and external 
chemical stress. Bacteria majorly make use of cultured regu-
lated cascades that perceive and distinguish toxic compounds 
and respond through various resistance mechanisms includ-
ing regulation of Omps.6,7,15,18,22 The information on the role 
of effective Omps in substrate uptake and their structural 
relationship associated with their role in transport highlights 
the efforts of the scientific upfront in the direction of under-
standing the bacterial resistance.6,7,15,18,22 Translocation across 
the Omps can be assumed as the first step in the journey of an 
antibiotic along the defined pathway toward its target. Con-
sequently, interpretation of antibiotic translocation through 
porins at the molecular level is crucial for understanding the 
correlation between influx and antibiotic activities within 
bacteria. The function of the general diffusion pores has 
been well studied based on pore characteristics, chemical 
modification, and genetic mutations. Our understanding of 
the structure of the pore-forming complex has tremendously 
improved over the last decade with the emergence of MS, 
state-of-the-art X-ray data, mass spectrometry assay pro-
tocols, and novel high-resolution experimental approaches 
including electrophysiology. However, a better understanding 
of the transportation mechanism by outer membrane pores 
is required. The molecular basis of the antibiotic transport 
via specific porins is still completely open at present, and 
further rigorous studies are needed to give insight into the 
structure–activity relationship of pores associated with anti-
biotic transport. The data computed for these Omps can be 
further employed to elucidate the antibiotic uptake pathway 
through Omps at molecular level, which could possibly 
empower rational drug design to further enhance permeation 
and  support novel strategies to dodge “impermeability”-
mediated resistance mechanism.
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